









Markets
/
Stocks
/
nasdaq-lrtx
/

Lirum Therapeutics Ord Shs (Proposed)

LRTX

0.000

Close 12/24, 13:00（ET）Quotes delayed by 15 min

--Market Cap

--P/E TTM



Lirum Therapeutics Ord Shs (Proposed)

0.000

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can check out the annual or quarterly balance sheets of Lirum Therapeutics Ord Shs (Proposed) here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2024Q1

Total equity

Cash, cash equivalents and short-term investments

--3.27M

- Cash and cash equivalents

--3.27M

Other current assets

--786.62K

Total current assets

--4.05M

Non-current assets

Total assets

--4.05M

Liabilities

Current liabilities

Accrued expenses

--1.49M

Total current liabilities

--2.40M

Non-current liabilities

Long-term debt and lease liabilities

--0.00

Total liabilities

--2.40M

Shareholders' equity

Common equity

--6.54M

Retained earnings

---4.89M

Capital reserves

--6.53M

Total equity

--1.65M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

